Back to search

Netherlands· NL-cd1c2ad357e1

Sofradex, oogdruppels

A dexamethason mit antiinfektiva product containing dexamethason natriummetasulfobenzoaat + framycetinesulfaat + gramicidine, registered in Netherlands by CHEPLAPHARM Arzneimittel GmbH. The same ATC class is registered in 11 of our 19 countries.

ATC S01CA01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedSofradex, oogdruppelsATCS01CA01REGISTER NO.NL-cd1c2ad357e1PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Dexamethason mit antiinfektiva is registered in 11 of 19 countries.

Countries holding a registration under ATC S01CA01 (dexamethason mit antiinfektiva), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose

Dexamethason mit antiinfektiva · ATC S01CA01

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
DEXAMETHASON NATRIUMMETASULFOBENZOAAT + FRAMYCETINESULFAAT + GRAMICIDINE
Manufacturer
CHEPLAPHARM Arzneimittel GmbH
Country
Netherlands (NL)
ATC code
S01CA01
ATC class
Dexamethason mit Antiinfektiva
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    15026

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/3f9017af-4e31-4697-bd82-416a794a0e92
GET /v1/drugs/3f9017af-4e31-4697-bd82-416a794a0e92?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oogdruppels, oplossing",
  "route": "Oculair gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h15026_smpc.pdf",
  "strength": null,
  "atc_label": "Dexamethasone And Antiinfectives",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg15026",
  "excipients": [
    "CITROENZUUR 1-WATER (E 330)",
    "ETHANOL, GEDENATUREERD MET METHANOL",
    "FENETHYLALCOHOL",
    "LITHIUM CHLORIDE",
    "NATRIUMHYDROXIDE (E 524)",
    "POLYSORBAAT 80 (E 433)",
    "TRINATRIUMCITRAAT 2-WATER (E 331)",
    "WATER VOOR INJECTIE",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "DEXAMETHASON NATRIUMMETASULFOBENZOAAT",
    "FRAMYCETINESULFAAT",
    "GRAMICIDINE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h15026.pdf",
  "authorised_at": "1990/10/30",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "15026",
  "additional_monitoring": "N"
}

See everything about dexamethason mit antiinfektiva.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.